NSN 6505-01-573-5290
Part Details | DROSPIRENONE AND ET
6505-01-573-5290
Alternate Parts: NDC50419040203, NDC50419-0402-03, YASMIN, 11275, 6505NCM093293, NDC68180090213, NDC68180-0902-13, NDC51862003603, NDC51862-0036-03, ZARAH, NDC00781565815, NDC00781-5658-15, SYEDA, OCELLA, NDC00555913167, NDC00555-9131-67, 6505-01-573-5290, 01-573-5290, 6505015735290, 015735290
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-573-5290
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC50419-0402-03 | 59463 | BAYER HEALTHCARE PHARMACEUTICALSINC. |
| YASMIN | 59463 | BAYER HEALTHCARE PHARMACEUTICALSINC. |
| 11275 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM093293 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC68180-0902-13 | 673J1 | LUPIN PHARMACEUTICALS, INC. |
| NDC51862-0036-03 | 4HH72 | MAYNE PHARMA INC. |
| ZARAH | 4HH72 | MAYNE PHARMA INC. |
| NDC00781-5658-15 | 0THL4 | SANDOZ INC. |
| SYEDA | 0THL4 | SANDOZ INC. |
| OCELLA | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
| NDC00555-9131-67 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-573-5290
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | EACH TABLETS CONTAINS 3 MG OF DROSPIRENONE AND 0.03 MG. OF ETHINYL ESTRADIOL ACTIVE INGREDIENT; FILM COATED 28 TABLETS PER CYCLE; 3 CYCLES PER PACKAGE; EA. CYCLE CONTAINS 21 TABLETS W/HORMONES, 7 TABLETS W/O HORMONES; 28 TABLETS X 3 CYCLES. STORE AT 20 TO 25 C(68 TO 77 F).EXCURSIONS PERMITTED TO 15-30 C (59-86 F)?SEE USP CONTROLLED ROOM TEMPERATURE|.COMPARABLE TO YASMIN. |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| SUPPLEMENTARY FEATURES | 3 CYCLES PER PKG; CONTAINS 28 TABS BY 3 CYCLES TOTAL NUMBER OF TABS: 84 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DROSPIRENONE ETHINYL ESTRADIOL 3 CYCLES 28 TABS TOTAL 84 TABS |
